Suicide Specific Rumination in Veterans
Reducing Suicide-Specific Rumination in Veterans Using Real-time Functional Magnetic Resonance Imaging Neurofeedback
1 other identifier
interventional
15
1 country
1
Brief Summary
Few treatments target core features of suicidal thoughts and behaviors in Veterans. Real-time functional magnetic resonance imaging neurofeedback can provide information regarding brain activation associated with suicide-specific rumination, defined as a "repetitive mental fixation on one's suicidal thoughts and intentions." The goal of this feasibility study is for Veterans to learn strategies for modulating activity within brain regions that have been demonstrated to contribute to the maintenance of rumination, as they receive neurofeedback feedback signals from the brain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Aug 2024
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
July 31, 2025
July 1, 2025
2 years
June 17, 2024
July 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Acceptability and Feasibility
The Client Satisfaction Questionnaire will be used to assess acceptability and feasibility of implementing real-time fMRI neurofeedback in a Veteran population. The total score on the questionnaire ranges from from 8 to 32 with higher scores indicative of greater satisfaction.
Total score obtained 2 weeks following first real-time fMRI neurofeedback session.
Secondary Outcomes (1)
Suicide Rumination Scale
Change in total score from pre-treatment to post-treatment (2 weeks).
Study Arms (1)
Real-time fMRI Neurofeedback
EXPERIMENTALThis is a pilot study to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging feedback for veterans experiencing suicide-specific rumination. All study participants will receive the intervention.
Interventions
The proposed pilot study is designed to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging (rt-fMRI) feedback in reducing suicide-specific rumination in veterans. Fifteen veterans will receive 2 rt-fMRI neurofeedback sessions while attempting to alter connectivity in brain regions that play a role in rumination. Pre- and post-treatment assessments of suicide, disability, functional impairment, and quality of life will be collected.
Eligibility Criteria
You may qualify if:
- U.S. military veteran between 18-65 years old
- negative pregnancy test on MRI scan days
- score greater than or equal to 10 on the Suicide Rumination Scale
- clinically stabilized on psychotropic medications
- engaged in mental health care treatment
- able to provide written, informed consent
You may not qualify if:
- no major medical or neurological disorders that could interfere with treatment
- moderate or severe traumatic brain injury
- current imminent suicide risk, as determined through psychiatric interview, responses to C-SSRS, and clinical judgment of the assessor
- any current psychotic disorder
- MRI contraindications
- any substance use disorder for substances other than cannabis or alcohol (mild alcohol or cannabis use disorder does not exclude participants but moderate or severe alcohol or cannabis substance use disorder is disqualifying)
- pregnant or trying to become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip R Szeszko, PhD
James J. Peters Veterans Affairs Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2024
First Posted
July 1, 2024
Study Start
August 1, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- Data will be shared with scientific collaborators after the data have been analyzed and submitted for publication.
- Access Criteria
- De-identified data will be shared when the study is completed and following IRB approval.
The investigators will obtain IRB approval prior to sharing de-identified data.